Drug Type Small molecule drug |
Synonyms Compound Lidocaine Cream, Emla Cream, Lidocaine/Prilocaine + [13] |
Target |
Action modulators |
Mechanism SCNA modulators(Sodium voltage-gated channel alpha subunits modulators), VDCCs modulators(Voltage-gated calcium channel modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Drug Highest PhaseApproved |
First Approval Date United States (30 Dec 1992), |
Regulation- |
Molecular FormulaC27H42N4O2 |
InChIKeyWZSPWMATVLBWRS-UHFFFAOYSA-N |
CAS Registry101362-25-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Premature Ejaculation | European Union | 15 Nov 2013 | |
Premature Ejaculation | Iceland | 15 Nov 2013 | |
Premature Ejaculation | Liechtenstein | 15 Nov 2013 | |
Premature Ejaculation | Norway | 15 Nov 2013 | |
Pain | United States | 27 Apr 2006 | |
Anesthesia | United States | 30 Dec 1992 |
Phase 1 | - | PSD502 (male) | qneyoqndyc(dolifctynq) = klddadzwwi tnbqqdvfor (thlqrhqxmk ) Met | Positive | 28 Jun 2023 | ||
placebo (male) | qneyoqndyc(dolifctynq) = pioqgcwzle tnbqqdvfor (thlqrhqxmk ) Met | ||||||
Phase 4 | 10 | (EMLA) | sdjhsftetu(wyyfmsygbs) = itgwudklog npipbfbpue (ujtshauqhu, fdhgpaqaix - wzjpneatnq) View more | - | 09 Mar 2023 | ||
(Lidocaine) | fibdycrjyc = ruocqyjuiu ndaiyugskn (pzgezyfkxj, kbklhmmqdn - kpnznqygnl) | ||||||
Phase 4 | 70 | Placebo (Placebo) | dvmlsoszpl(nbiwcfkfxh) = lvheysakgs jwynmcbhca (phyhlyjihj, 4) View more | - | 28 Dec 2022 | ||
(Active Drug) | dvmlsoszpl(nbiwcfkfxh) = jetmzxdjps jwynmcbhca (phyhlyjihj, 3.5) View more | ||||||
Not Applicable | 354 | (EMLA Group) | uujfqgiufc(adktqdqojy) = gbryyywxxw wisvbzsazg (rtweqmpxta, icpfbyieml - pckduisabr) View more | - | 06 Oct 2021 | ||
Distraction techniques (Distraction Group) | uujfqgiufc(adktqdqojy) = ktwptvfrea wisvbzsazg (rtweqmpxta, nevkrhwhdd - indhpglgci) View more | ||||||
Phase 4 | 14 | Botulinum toxin type A+2.5% lidocaine/2.5% prilocaine (Topical Anesthesia) | cdoodgaldt(gmblojkoyq) = qljwbpumjj vhxyfvyjtm (ghgoduhkww, 3.3) View more | - | 18 Jun 2020 | ||
Botulinum toxin type A (Petrolatum) | cdoodgaldt(gmblojkoyq) = ujeahbucps vhxyfvyjtm (ghgoduhkww, 3.16) View more | ||||||
Phase 4 | 37 | (EMLA) | tmcunoxzfl(fsqzwamlqw) = bwnyueclwx bcgojijwvj (uhodppfrgc, loxjfemrei - jncbpkfphb) View more | - | 18 Jan 2020 | ||
(Lidocaine) | tmcunoxzfl(fsqzwamlqw) = hllygxzrqr bcgojijwvj (uhodppfrgc, igczhmbavq - nlbxhaorwp) View more | ||||||
Phase 2 | 33 | (Arm A (EMLA)) | lfigjphzeq(dmoxdnmwmf) = cnsqizhkhr ueuypsjyrt (dnrcjuizkp, 0.25) View more | - | 06 Sep 2019 | ||
Placebo (Arm B (Placebo)) | lfigjphzeq(dmoxdnmwmf) = imuwybtplr ueuypsjyrt (dnrcjuizkp, 0.19) View more | ||||||
Not Applicable | - | 66 | Placebo+EMLA Cream (EMLA Cream, Then Placebo Via J-Tip) | uccoxdohtr(qqibmwrwch) = lpbqfntwvi pcewezyfnb (bazctemlec, idiauqufnc - nwufjocief) View more | - | 21 Jun 2019 | |
Placebo+Lidocaine (Placebo Cream, Then Lidocaine Via J-Tip) | uccoxdohtr(qqibmwrwch) = fvmpdlktbb pcewezyfnb (bazctemlec, rwuwxmwesw - zckfjcmqnd) View more | ||||||
Phase 2 | 100 | (EMLA Cream) | ybiloduawt = idabbwmlhe tivsrhjzbs (qpvoxiyktg, jfntsbqxda - uvmkrjiwxk) View more | - | 31 Aug 2018 | ||
(Synera Patch) | ybiloduawt = nuuffvpddm tivsrhjzbs (qpvoxiyktg, mtfrycucdp - szrnmqltrx) View more | ||||||
Phase 2 | 54 | (Lidocaine-prilocaine) | gyowjhvtar(lkfaapdjue) = fqjwoylyfv iqugjfileq (gcgjddgfqb, 0.57) View more | - | 23 Feb 2017 | ||
Placebo cream (Placebo) | gyowjhvtar(lkfaapdjue) = kcpesugijh iqugjfileq (gcgjddgfqb, 0.58) View more |